You have 7 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

LP-284

Showing 26 - 50 of 428
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Acute Coronary Syndrome, Lipoprotein Disorder, Acute Myocardial Infarction Trial in Caserta

Recruiting
  • Acute Coronary Syndrome
  • +3 more
    • Caserta, Italy
      AORN S. Anna e S. Sebastiano
    Aug 9, 2022

    Lipoprotein Disorder Trial in Worldwide (LY3473329, Placebo)

    Recruiting
    • Lipoprotein Disorder
    • Liverpool, New South Wales, Australia
    • +46 more
    Jan 18, 2023

    Clinical Pharmacology Trial ([14C]LP-168)

    Not yet recruiting
    • Clinical Pharmacology
    • (no location specified)
    Nov 13, 2023

    CLL/SLL, Waldenstrom Macroglobulinemia, Follicular Lymphoma Trial in Cincinnati, Columbus, Salt Lake City (LP-168)

    Recruiting
    • CLL/SLL
    • +6 more
    • Cincinnati, Ohio
    • +2 more
    May 7, 2022

    N/LP Ratio as Predictor of Mortality in Septic AKI Patients

    Not yet recruiting
    • Acute Kidney Injury Due to Sepsis
      • (no location specified)
      Oct 1, 2022

      Thrombogenicity of Lipoprotein A: Laboratory Study Defining

      Not yet recruiting
      • Cardiovascular Disease and Lipid Disorders
      • Cardiac Disease
      • Non-interventional
      • Middlesbrough, Teesside, United Kingdom
        South Tees Hospitals NHS FT
      Apr 14, 2022

      Lipoprotein-associated Phospholipase A2 in Type 2 Diabetes

      Completed
      Has Results
      • Type2 Diabetes
        • (no location specified)
        Apr 12, 2022

        Cardiac Rhythm Disorder, Bradycardia Trial in Worldwide (Aveir VR Leadless Pacemaker System)

        Active, not recruiting
        • Cardiac Rhythm Disorder
        • Bradycardia
        • Aveir VR Leadless Pacemaker System
        • Birmingham, Alabama
        • +52 more
        Dec 16, 2022

        Mantle Cell Lymphoma (MCL) Trial in China (LP-168)

        Not yet recruiting
        • Mantle Cell Lymphoma (MCL)
        • Hefei, Anhui, China
        • +29 more
        Feb 7, 2023

        Cardiovascular Disease and Lipoprotein(a) Trial in Worldwide (TQJ230, Placebo)

        Active, not recruiting
        • Cardiovascular Disease and Lipoprotein(a)
        • Andalusia, Alabama
        • +791 more
        Oct 7, 2022

        Pediatric, Bacterial Infections Trial in Cincinnati (amoxicillin-clavulanic acid)

        Not yet recruiting
        • Pediatric
        • Bacterial Infections
        • amoxicillin-clavulanic acid
        • Cincinnati, Ohio
          Cincinnati Children's Hospital Medical Center
        Oct 14, 2022

        Lp(a) With CCTA Assessed Parameters and Clinical Outcomes

        Recruiting
        • Coronary Artery Disease
        • Coronary CTA
        • Shanghai, China
          Shanghai Zhongshan Hospital
        Apr 4, 2022

        Atherosclerotic Cardiovascular Disease Trial in United States (Inclisiran)

        Recruiting
        • Atherosclerotic Cardiovascular Disease
        • Little Rock, Arkansas
        • +43 more
        Jan 20, 2023

        Cardiovascular Diseases Trial in Shatin (TQJ230, Placebo)

        Active, not recruiting
        • Cardiovascular Diseases
        • Shatin, Hong Kong
          The Chinese University of Hong Kong
        Sep 16, 2022

        Acute Coronary Syndrome, Lipoproteinemia, Inflammation Trial in Ljubljana (Pelacarsen (TQJ230), Placebo)

        Withdrawn
        • Acute Coronary Syndrome
        • +3 more
        • Pelacarsen (TQJ230)
        • Placebo
        • Ljubljana, Slovenia
          University Medical Centre Ljubljana-Department of Vascular disea
        Dec 10, 2021

        Dermatitis, Atopic Trial in Worldwide (Dupilumab, Matching Placebo, Background Treatment: Topical Corticosteroids)

        Completed
        Has Results
        • Dermatitis, Atopic
        • Birmingham, Alabama
        • +60 more
        Jul 30, 2020

        Postpartum Depression, Preterm Infant, Infant Development Trial in Boston (Newborn Behavioral Observation-Family Wellness

        Completed
        • Postpartum Depression
        • +2 more
        • Newborn Behavioral Observation-Family Wellness (NBO-FW)
        • Boston, Massachusetts
          Brigham and Women's Hospital
        Aug 15, 2022

        Cholesterol; Metabolic Disorder, Lipoproteinemia Trial in Nantes (infusion of tracer [5,5,5-2H3] -L-leucine)

        Completed
        • Cholesterol; Metabolic Disorder
        • Lipoproteinemia
        • infusion of tracer [5,5,5-2H3] -L-leucine
        • Nantes, France
          Nantes University Hospital
        Feb 22, 2022

        Chronic Hepatitis b Trial in Guangzhou (LP-128 capsules, Matching Placebo)

        Recruiting
        • Chronic Hepatitis b
        • LP-128 capsules
        • Matching Placebo
        • Guangzhou, Guangdong, China
          NanFang Hospital of Southern Medical University
        Aug 2, 2022

        Multiple Sclerosis, NMO Spectrum Disorder Trial in Hangzhou (LP-168 tablet, LP-168 Placebo tablet)

        Recruiting
        • Multiple Sclerosis
        • NMO Spectrum Disorder
        • LP-168 tablet
        • LP-168 Placebo tablet
        • Hangzhou, Zhejiang, China
          The Second Affiliated Hospital Zhejiang University School of Med
        Jun 26, 2022

        Leukemia Trial in Aurora (Virtual Reality)

        Recruiting
        • Leukemia
        • Virtual Reality
        • Aurora, Colorado
          Children's Hospital Colorado
        Aug 22, 2022

        Aveir VR Coverage With Evidence Development Post-Approval Study

        Recruiting
        • Cardiac Pacemaker
        • +2 more
        • Aveir VR Leadless Pacemaker System
        • Single-Chamber Transvenous Pacemaker
        • Sylmar, California
          Abbott
        Sep 20, 2022

        Lymphedema of Genitalia Trial in Montpellier Cedex 5, Paris, Toulouse (MOBIDERM Panty group)

        Completed
        • Lymphedema of Genitalia
        • MOBIDERM Panty group
        • Montpellier Cedex 5, France
        • +2 more
        Jan 10, 2022

        Type 2 Diabetes, Blood Pressure Trial in Lubbock (DASH-FP, DASH-NFP, Control)

        Recruiting
        • Type 2 Diabetes
        • Blood Pressure
        • DASH-FP
        • +2 more
        • Lubbock, Texas
          Texas Tech University
        Oct 19, 2022

        SARS CoV 2 Infection, COVID-19 Trial in Brussels (Humoral immunity)

        Enrolling by invitation
        • SARS CoV 2 Infection
        • COVID-19
        • Humoral immunity
        • Brussels, Belgium
          Sciensano
        Jan 16, 2023